Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × OTHER × TIC10 compound × Clear all

Phase

Phase 2 6 Phase 1 5 Phase 1/2 2 Phase 3 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Diffuse Intrinsic Pontine Glioma 1

Interventions

Cisplatin 241 Radiotherapy 202 Fluorouracil 172 Cyclophosphamide 166 Capecitabine 163 Docetaxel 146 Oxaliplatin 139 Gemcitabine 134 Carboplatin 130 Paclitaxel 128 Dexamethasone 110 Leucovorin 102 Drug Therapy 101 Doxorubicin 99 Etoposide 84 Cytarabine 76 Bevacizumab 75 Vincristine 72 Irinotecan 66 Rituximab 64 Epirubicin 63 Methotrexate 55 Prednisone 54 Radiosurgery 52 Surgical Procedures, Operative 50 Radiotherapy, Intensity-Modulated 49 Radiation 49 Neoadjuvant Therapy 48 Lenalidomide 48 Chemotherapy, Adjuvant 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05476939 2026-02-05

BIOMEDE 2

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Recruiting

Diffuse Intrinsic Pontine Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡